DK1620113T3 - Topisk formulering af ivermectin til behandling af dermatologiske lidelser - Google Patents

Topisk formulering af ivermectin til behandling af dermatologiske lidelser

Info

Publication number: DK1620113T3
Authority: DK; Denmark
Prior art keywords: ivermectin; treatment; topical formulation; dermatological disorders; dermatological
Prior art date: 2003-04-24

Application number

DK04728811.3T

Other languages

English (en)

Inventor

Vincent Manetta

Gary R Watkins

Original Assignee

Galderma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-24

Filing date

2004-04-22

Publication date

2011-09-12

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33104376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1620113(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-04-22 Application filed by Galderma Sa filed Critical Galderma Sa

2004-04-22 Priority claimed from PCT/EP2004/004950 external-priority patent/WO2004093886A1/en

2011-09-12 Application granted granted Critical

2011-09-12 Publication of DK1620113T3 publication Critical patent/DK1620113T3/da

Links

AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 title 1
SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 title 1
229960002418 ivermectin Drugs 0.000 title 1
239000012049 topical pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Dispersion Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK04728811.3T 2003-04-24 2004-04-22 Topisk formulering af ivermectin til behandling af dermatologiske lidelser DK1620113T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0305048A FR2854074B1 (fr)	2003-04-24	2003-04-24	Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
US46899403P	2003-05-09	2003-05-09
PCT/EP2004/004950 WO2004093886A1 (en)	2003-04-24	2004-04-22	Topical formulation of ivermectin for the treatment of dermatological conditions

Publications (1)

Publication Number	Publication Date
DK1620113T3 true DK1620113T3 (da)	2011-09-12

Family

ID=33104376

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04728811.3T DK1620113T3 (da)	2003-04-24	2004-04-22	Topisk formulering af ivermectin til behandling af dermatologiske lidelser

Country Status (11)

Country	Link
US (6)	US8815816B2 (da)
KR (1)	KR101291824B1 (da)
CN (2)	CN103800353A (da)
AR (1)	AR044050A1 (da)
AT (1)	ATE516037T1 (da)
DK (1)	DK1620113T3 (da)
ES (1)	ES2371945T3 (da)
FR (1)	FR2854074B1 (da)
PT (1)	PT1620113E (da)
SI (1)	SI1620113T1 (da)
ZA (1)	ZA200507346B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2867684B1 (fr) *	2004-03-18	2006-05-05	Galderma Sa	Gel creme contenant de l'ivermectine
DE602005020912D1 (de)	2004-03-18	2010-06-10	Galderma Sa	Ivermectin enthaltende creme
FR2883181B1 (fr)	2005-03-17	2007-05-18	Galderma Sa	Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee
WO2008067054A2 (en)	2006-10-12	2008-06-05	Topaz Pharmaceuticals Llc	Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment-resistant strains of head lice
US7953614B1 (en)	2006-11-22	2011-05-31	Dr Systems, Inc.	Smart placement rules
EP2348832B2 (en) *	2008-10-29	2024-12-25	Arbor Pharmaceuticals, LLC	Preservative system for emulsion-based therapeutic topical formulations
CN102784166B (zh) *	2012-08-01	2015-11-25	青岛绿曼生物工程有限公司	治疗家畜螨虫病的复方伊维菌素组合物及其制备方法
CN103356687B (zh)	2012-10-19	2016-06-01	厦门大学	一种伊维菌素及其衍生物的用途
US9233118B2 (en) *	2013-07-08	2016-01-12	Galderma S.A.	Treatment of papulopustular rosacea with ivermectin
CA2930909A1 (en)	2013-11-29	2015-06-04	Galderma Sa	Compound of the avermectin family or of the milbemycin family for the treatment and/or prevention of atopic dermatitis
JP2017508762A (ja)	2014-03-28	2017-03-30	ガルデルマ・リサーチ・アンド・デヴェロップメント	過酸化ベンゾイルを含有するすすがない化学的ムース剤
US20170232024A1 (en)	2014-08-04	2017-08-17	Jerry Tan Eye Surgery Pte Ltd	Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
CN104127334A (zh) *	2014-08-19	2014-11-05	杨人源	一种杀菌除螨宠物香波
US10653659B2 (en)	2014-11-20	2020-05-19	Galderma S.A.	Compositions comprising a compound from the family of avermectins and an agonist compound for at least one of the retinoic acid receptors for treating acne
FR3041535B1 (fr)	2015-09-29	2019-01-25	Galderma Research & Development	Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'ichtyose.
FR3041538B1 (fr)	2015-09-29	2018-11-30	Galderma Research & Development	Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041540B1 (fr) *	2015-09-29	2018-10-26	Galderma Research & Development	Composition nettoyante auto-moussante a rincer, contenant de l'ivermectine.
FR3041537B1 (fr)	2015-09-29	2018-11-30	Galderma Research & Development	Mousse chimique non rincee contenant de la brimonidine et son utilisation dans le traitement de la rosacee.
FR3041539B1 (fr)	2015-09-29	2018-10-26	Galderma Research & Development	Composition nettoyante auto-moussante contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
FR3041536B1 (fr)	2015-09-29	2018-11-30	Galderma Research & Development	Mousse chimique non rincee contenant du trifarotene, et son utilisation dans le traitement de l'acne.
FR3041541B1 (fr)	2015-09-29	2018-11-30	Galderma Research & Development	Mousse chimique non rincee comprenant de l'ivermectine
CA3000898A1 (en) *	2015-10-13	2017-04-20	Galderma Sa	A process for preparing a stable emulsion comprising one or more avermectins
WO2018060870A1 (en) *	2016-09-30	2018-04-05	Aurobindo Pharma Limited	Pharmaceutical composition of ivermectin and process for preparation thereof
TR201714097A2 (tr) *	2017-09-22	2018-10-22	Assos Ilac Kimya Gida Ueruenleri Ueretim Ve Ticaret Anonim Sirketi	İvermekti̇n topi̇k formülasyon
EP3723739B1 (en)	2017-12-15	2024-03-27	Tarsus Pharmaceuticals, Inc.	Isoxazoline parasiticide formulations and their use for treating blepharitis
US20210077559A1 (en) *	2018-01-05	2021-03-18	Attillaps Holdings	Treating Autoimmune Disorders with Acetylcholinesterase Inhibitors
WO2019152560A1 (en) *	2018-01-31	2019-08-08	Bio33 Degrees, Inc.	Compositions and methods for topical treatment of dermal and ocular conditions
CN108272750A (zh) *	2018-04-25	2018-07-13	菏泽学院	一种治疗动物皮肤疥癣病的软膏剂及其制备方法
WO2021247283A1 (en) *	2020-06-04	2021-12-09	Amcyte Pharma, Inc.	Delivery of aerosolized micromolar composition concentrations

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
OA06863A (fr)	1980-08-04	1983-02-28	Merck & Co Inc	Solubilisation de l'invermectine dans l'eau.
US5332577A (en) *	1988-12-27	1994-07-26	Dermamed	Transdermal administration to humans and animals
FR2725369B1 (fr) *	1994-10-07	1997-01-03	Oreal	Composition cosmetique ou dermatologique constituee d'une emulsion huile dans eau a base de globules huileux pourvus d'un enrobage cristal liquide lamellaire
US5656280A (en)	1994-12-06	1997-08-12	Helene Curtis, Inc.	Water-in-oil-in-water compositions
AU713580B2 (en)	1995-09-25	1999-12-02	Merial Ltd	Anthelmintic macrocyclic lactone compositions
FR2754452B1 (fr)	1996-10-11	2003-02-14	Oreal	Emulsion h/e a forte teneur en electrolytes et leur utilisation en dermo-cosmetique, notamment pour traiter les phenomenes d'irritation et/ou de peaux sensibles
US5952372A (en) *	1998-09-17	1999-09-14	Mcdaniel; William Robert	Method for treating rosacea using oral or topical ivermectin
US6521237B2 (en) *	1998-11-12	2003-02-18	Johnson & Johnson Consumer Companies, Inc.	Skin care composition
FR2787322B1 (fr)	1998-12-18	2002-10-18	Galderma Res & Dev	Emulsion huile-dans-eau comprenant un agent actif micronise et un systeme emulsionnant approprie
US6133310A (en) *	1999-08-26	2000-10-17	Parks; L. Dean	Method of treatment of rosacea
US6720001B2 (en) *	1999-10-18	2004-04-13	Lipocine, Inc.	Emulsion compositions for polyfunctional active ingredients
US6319945B1 (en) *	2000-06-29	2001-11-20	L. Dean Parks	Method of treatment of seborrheic dermatitis
US6399651B1 (en) *	2000-06-29	2002-06-04	L. Dean Parks	Method of treating dermatoses using avermectin compound
US6399652B1 (en) *	2000-06-29	2002-06-04	L. Dean Parks	Method of treating acne vulgaris using avermectin compound
US7064108B2 (en)	2002-02-08	2006-06-20	Merck & Co., Inc.	Topical ivermectin composition
CA2478589A1 (en)	2002-03-04	2003-09-18	Divergence, Inc.	Nematicidal fatty acid and fatty acid ester related compounds
PL378932A1 (pl)	2003-04-24	2006-06-12	Galderma S.A.	Zastosowanie ivermectiny do leczenia schorzeń dermatologicznych
DE602005020912D1 (de)	2004-03-18	2010-06-10	Galderma Sa	Ivermectin enthaltende creme
FR2867684B1 (fr)	2004-03-18	2006-05-05	Galderma Sa	Gel creme contenant de l'ivermectine

2003
- 2003-04-24 FR FR0305048A patent/FR2854074B1/fr not_active Expired - Fee Related
2004
- 2004-04-22 SI SI200431722T patent/SI1620113T1/sl unknown
- 2004-04-22 DK DK04728811.3T patent/DK1620113T3/da active
- 2004-04-22 AR ARP040101354A patent/AR044050A1/es not_active Application Discontinuation
- 2004-04-22 AT AT04728811T patent/ATE516037T1/de active
- 2004-04-22 KR KR1020127013727A patent/KR101291824B1/ko active IP Right Grant
- 2004-04-22 PT PT04728811T patent/PT1620113E/pt unknown
- 2004-04-22 CN CN201310731121.9A patent/CN103800353A/zh active Pending
- 2004-04-22 CN CNA2004800109954A patent/CN1777433A/zh active Pending
- 2004-04-22 ES ES04728811T patent/ES2371945T3/es not_active Expired - Lifetime
2005
- 2005-09-13 ZA ZA200507346A patent/ZA200507346B/xx unknown
2013
- 2013-10-25 US US14/063,897 patent/US8815816B2/en not_active Expired - Lifetime
2014
- 2014-07-22 US US14/337,966 patent/US20140336139A1/en not_active Abandoned
2015
- 2015-07-06 US US14/792,250 patent/US20150306027A1/en not_active Abandoned
- 2015-07-06 US US14/792,201 patent/US20150306124A1/en not_active Abandoned
2017
- 2017-06-16 US US15/625,239 patent/US20170281663A1/en not_active Abandoned
- 2017-06-16 US US15/625,362 patent/US11033565B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
SI1620113T1 (sl)	2011-10-28
ES2371945T3 (es)	2012-01-11
US20140051653A1 (en)	2014-02-20
PT1620113E (pt)	2011-09-12
FR2854074A1 (fr)	2004-10-29
ZA200507346B (en)	2006-08-30
US11033565B2 (en)	2021-06-15
CN103800353A (zh)	2014-05-21
FR2854074B1 (fr)	2007-11-23
US20140336139A1 (en)	2014-11-13
KR101291824B1 (ko)	2013-07-31
ATE516037T1 (de)	2011-07-15
CN1777433A (zh)	2006-05-24
US20170281664A1 (en)	2017-10-05
US8815816B2 (en)	2014-08-26
AR044050A1 (es)	2005-08-24
US20150306027A1 (en)	2015-10-29
US20170281663A1 (en)	2017-10-05
US20150306124A1 (en)	2015-10-29
KR20120062028A (ko)	2012-06-13

Publication	Publication Date	Title
DK1620113T3 (da)	2011-09-12	Topisk formulering af ivermectin til behandling af dermatologiske lidelser
CY2016031I1 (el)	2017-03-15	Τοπικη φαρμακοτεχνικη μορφη ιβερμεκτινης για την θεραπεια δερματολογικων καταστασεων
ITMI20020756A1 (it)	2003-10-09	Composizioni farmaceutiche topiche per il trattamento delle dermatiti
PT1485127E (pt)	2011-09-07	Administração de agentes para o tratamento de inflamação
DK1304992T3 (da)	2009-08-10	Topisk gel-fremföringssystem til behandling af hudlidelser
DK1803718T3 (da)	2008-10-27	4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter
IS8398A (is)	2006-04-05	Lyfjasamsetningar til að meðhöndla æxli
CY2013022I1 (el)	2020-05-29	Συνθεσεις για την θεραπευτικη αγωγη γαστρεντερικων διαταραχων
IS7099A (is)	2004-01-08	Efnasambönd til að meðhöndla bólgutruflanir
DK1480615T3 (da)	2010-07-12	Superfin formoterolformulering
NO20053077D0 (no)	2005-06-23	Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
IS7691A (is)	2005-02-09	Lyfjasamsetningar til að meðhöndla æxli
EP1727530A4 (en)	2009-10-21	TOPICAL FORMULATIONS FOR THE TREATMENT OF DERMATOLOGICAL CONDITIONS
IS8023A (is)	2005-09-13	Samsett meðferð til að meðhöndla ónæmisbólgusjúkdóma
NO20053211D0 (no)	2005-06-30	Forbindelser for behandling av metabolske forstyrrelser.
DK1448205T3 (da)	2011-12-12	Kombinationer til behandling af immunoinflammatoriske sygdomme
DK1499730T3 (da)	2014-01-13	Immunokonjugater til behandling af tumorer
ATE476200T1 (de)	2010-08-15	Topische nepafenac-formulierungen
CY2018006I1 (el)	2018-06-27	Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
ITMI20031311A0 (it)	2003-06-27	Formulazioni per il trattamento di disturbi artrosici
DE60234388D1 (de)	2009-12-24	Therapeutische lotion gegen dermatitis
DK1487828T3 (da)	2009-02-02	Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
EP1698330A4 (en)	2012-08-15	EXTERNAL ANALGESIC ANTI-INFLAMMATORY PREPARATION
DK1687297T3 (da)	2014-09-22	Triazindimerer til behandling af autoimmunsygdomme
DK1503747T3 (da)	2006-11-27	Diclofenacbaseret sammensætning til topisk behandling af sygdomme